- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Pasyukova, E. G.
- Articles by Mackay, T. F. C.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Pasyukova, E. G.
- Articles by Mackay, T. F. C.
Deficiency Mapping of Quantitative Trait Loci Affecting Longevity in Drosophila melanogaster
Elena G. Pasyukovaa,b, Cristina Vieira1,a, and Trudy F. C. Mackayaa Department of Genetics, College of Agriculture and Life Sciences, North Carolina State University, Raleigh, North Carolina 27695
b Institute of Molecular Genetics of the Russian Academy of Sciences, Moscow 123182, Russia
Corresponding author: Trudy F. C. Mackay, Department of Genetics, Box 7614, North Carolina State University, Raleigh, NC 27695., trudy_mackay{at}ncsu.edu (E-mail)
Communicating editor: J. B. WALSH
| ABSTRACT |
|---|
In a previous study, sex-specific quantitative trait loci (QTL) affecting adult longevity were mapped by linkage to polymorphic roo transposable element markers, in a population of recombinant inbred lines derived from the Oregon and 2b strains of Drosophila melanogaster. Two life span QTL were each located on chromosomes 2 and 3, within sections 33E46C and 65D85F on the cytological map, respectively. We used quantitative deficiency complementation mapping to further resolve the locations of life span QTL within these regions. The Oregon and 2b strains were each crossed to 47 deficiencies spanning cytological regions 32F44E and 64C76B, and quantitative failure of the QTL alleles to complement the deficiencies was assessed. We initially detected a minimum of five and four QTL in the chromosome 2 and 3 regions, respectively, illustrating that multiple linked factors contribute to each QTL detected by recombination mapping. The QTL locations inferred from deficiency mapping did not generally correspond to those of candidate genes affecting oxidative and thermal stress or glucose metabolism. The chromosome 2 QTL in the 35BE region was further resolved to a minimum of three tightly linked QTL, containing six genetically defined loci, 24 genes, and predicted genes that are positional candidates corresponding to life span QTL. This region was also associated with quantitative variation in life span in a sample of 10 genotypes collected from nature. Quantitative deficiency complementation is an efficient method for fine-scale QTL mapping in Drosophila and can be further improved by controlling the background genotype of the strains to be tested.
THE genetic architecture of many traits important to human health, agriculture, and adaptive evolution is complex, such that the observed quantitative variation in phenotypes is attributable to the segregation of multiple interacting loci whose effects are sensitive to the environment (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Well-known problems are that QTL analyses are restricted to identifying factors affecting the trait(s) of interest that are segregating in the mapping population, and the sample size necessary to detect QTL increases greater than linearly as the QTL effect diminishes (![]()
![]()
![]()
![]()
Life span is a typical quantitative trait, for which phenotypic variation in natural populations is attributable to both genetic and environmental components (![]()
![]()
![]()
![]()
![]()
The exact QTL locations differed somewhat according to whether a multiple marker regression-sequential search procedure (![]()
![]()
![]()
![]()
![]()
|
For the D. melanogaster model system, deficiency mapping is an effective method for localizing single gene mutations to small genetic regions. In this report, we investigate the utility of a quantitative version of deficiency mapping to fine-map QTL affecting adult Drosophila life span, using deficiencies spanning the 32F44E and 64C76B cytological regions on the second and third chromosomes, respectively. According to the QTL mapping analyses, the former contains one female-specific and from one to three male-specific QTL, while the latter harbors two male-specific QTL. Deficiency mapping reveals a rather more complicated genetic architecture.
The Oregon and 2b strains represent a highly restricted sample of genetic variation affecting life span. Are sex-specific effects on life span observed generally, or are they peculiar features of these particular strains? Are the same QTL associated with variation in life span in flies recently collected from nature? To address these questions, we also assessed variation in life span among inbred lines recently derived from a natural population and evaluated the genetic interactions between naturally occurring QTL affecting life span and deficiencies that interacted with QTL affecting variation in life span between Oregon and 2b.
| MATERIALS AND METHODS |
|---|
Drosophila stocks:
The unrelated isogenic laboratory lines 2b and Oregon RC are described in ![]()
![]()
![]()
|
Crosses and longevity assays:
Virgin females of 2b and Oregon (Ore) were crossed separately to males of the deficiency stocks listed in Table 1. Crosses with deficiencies from each chromosomal region containing putative QTL were made at the same time, with one exception involving six deficiencies noted below. The progeny of these crosses are of four genotypes, Df/2b, Bal/2b, Df/Ore, and Bal/Ore, where Df and Bal indicate the particular deficiency and the balancer chromosome against which it is maintained. Five virgin flies of the same genotype and sex that were collected on the same day were placed in a vial containing
5 ml of standard cornmeal-agar-molasses medium without live yeast on the surface. There were four replicate vials for each genotype and sex, for a total of 20 females and 20 males per genotype, or 160 individuals per cross. Flies were transferred to fresh medium approximately every 710 days. The number of dead and live flies was recorded in each vial every day. Rare escapers were noted and subtracted from further analysis, which reduced the sample sizes for some genotypes to 19 flies. The design was nearly completely balanced, with a total of 6549 flies scored. Longevity was estimated as the number of days a fly lived, from the day of eclosion to the day prior to registration of death.
Life span of the 10 inbred NC lines was measured in a similar way, except that there were five replicate vials per line, each containing five virgin males or females. One escaped fly reduced the total number of flies scored to 499. In addition, females of each of the 10 NC lines were crossed to males of three overlapping deficiency stocks that uncovered a putative QTL segregating between 2b and Oregon (see RESULTS for further explanation). Progeny of these crosses were collected and scored for life span, again with five replicate vials containing five flies for each NC line/deficiency line/deficiency genotype/sex combination. The experiment was nearly completely balanced, with a total of 2991 flies scored. Life span determinations for all homozygous NC lines and for the NC lines crossed to deficiency stocks were conducted at the same time.
Quantitative complementation test with deficiencies:
The experimental design and interpretation is analogous to the quantitative complementation test (![]()
![]()
![]()
![]()
The life span data from the four genotypes resulting from the cross of Oregon and 2b to each deficiency were analyzed by two-way factorial analysis of variance (ANOVA), with line L (Oregon and 2b) and genotype G (Df and Bal) as cross-classified main effects. A significant L x G interaction term is interpreted as quantitative failure to complement; i.e., the contrast (Df/Ore - Df/2b) - (Bal/Ore - Bal/2b) is significantly different from zero.
As for all genetic complementation tests, there are two possible interpretations of quantitative failure to complement: (i) the deficiency uncovers Oregon and 2b alleles with different quantitative effects on life span (allelism); and (ii) interactions occur between Oregon and 2b life span QTL with other life span QTL on the Df or Bal chromosome (epistasis). As only allelic interactions are interpretable in the context of deficiency mapping, we have imposed further constraints on the nature of the observed L x G interactions to minimize the possibility of confounding epistatic interactions. A significant statistical interaction can occur either from a change of variance (the difference between the Ore and 2b genotypes is larger in either the Df or Bal genetic background) or a change of rank order (the difference between Oregon and 2b alleles is in the opposite direction in the Df and Bal genetic backgrounds). In the first instance, excepting the case of complete dominance of QTL alleles uncovered by a deficiency, one expects that failure to complement from allelism will result in a greater difference in mean life span between the Df/Ore and Df/2b genotypes than between the Bal/Ore and Bal/2b genotypes. Thus, we have considered only those statistical interactions resulting from a change of variance in which the contrast (Df/Ore - Df/2b) is significantly different from zero, and the contrast (Bal/Ore - Bal/2b) is not significant. For interactions resulting from opposite effects of Oregon and 2b in the Df and Bal genotypes, we also excluded those in which the contrast (Bal/Ore - Bal/2b) was significantly different from zero as potentially arising from epistasis.
Typically, quantitative complementation tests utilize parental lines that differ significantly in mean performance for the trait of interest. In this case, the L term in the analysis of variance is often expected to be significant, since heterozygous genotypes formed by crossing the parental lines to a third line are also expected to differ in mean performance, under most genetic models. Thus, the L term is generally not considered in quantitative complementation analysis (![]()
![]()
![]()
![]()
![]()
![]()
Similar logic applies to the analysis of the NC lines, but with multiple tester lines the test for interaction is whether there is variation among the lines in the difference in life span between deficiency hemizygotes and balancer heterozygotes.
The main effect of G in the above analyses tests whether there is a difference in life span between the Df and Bal genotypes averaged over the Oregon and 2b backgrounds (or over the NC line backgrounds) and is not of interest.
Statistical analyses:
Distribution statistics, analyses of variance, and tests of significance of F-ratios using type III mean squares were estimated using SAS procedures MEANS and GLM (SAS INSTITUTE 1988). The full quantitative complementation test analysis was a three-way factorial analysis of variance according to the model

where L, G, and S are the fixed cross-classified main effects of line, genotype, and sex, and R is the random effect of replicate vial. In the full models, significant L x G x S interaction terms are indicative of a sex-specific failure to complement.
The data were also analyzed using reduced models for each sex separately,

since all of the longevity QTL described by ![]()
| RESULTS |
|---|
According to the QTL mapping results presented by ![]()
![]()
|
Mean longevities of the eight genotypic classes of progeny (males and females of genotypes Df/2b, Bal/2b, Df/Ore, and Bal/Ore) resulting from crosses of the 2b and Oregon lines to each of the 41 deficiencies are given in TABLE A1. Considerable variation in longevity was observed between genotypes for both sexes. Mean longevity varied from 20 to 84 days in males and from 32 to 90 days in females. Analyses of variance for each of the 41 deficiencies including the effects of sex (S), line (L), and genotype (G) in the model demonstrated significant effects of sex on longevity for 27 deficiencies and significant L x S and L x G x S interactions for 9 deficiencies (data not shown), consistent with the sex specificity of QTL effects on longevity observed previously (![]()
![]()
32F44E region:
Significant L and L x G effects on longevity were not found for deficiencies a, b, c, d, e, f, s, and t of the second chromosome (Table A2, Fig 1B). These deficiencies mark chromosomal fragments from 32F13 to 35B9C1 and from 42A12 to 43F44A.
In females, the L term was significant for deficiencies g and h, and the L x G term was significant for deficiency i. For deficiencies g and i, the (Df/Ore - Df/2b) contrast was significantly different from zero and the (Bal/Ore - Bal/2b) contrast was not significant, whereas for deficiency h, the former contrast was not significant while the latter was. We thus consider deficiencies g and i as exhibiting quantitative failure to complement resulting from allelism and the other deficiencies in the region as complementing the Oregon and 2b life span QTL. These deficiencies have a common region starting from 35B13; however, no longevity QTL are located up to 35B9C1, according to information obtained from other deficiencies. Thus, the distal end of a putative region containing one or more QTL can be fixed at the end of subsection B of section 35 or at the beginning of subsection C of section 35, depending on the precise proximal endpoint of Df(2L)64j (c), and the proximal end of the region extends to 35E6.
These data are not entirely consistent with a single female-specific QTL in the 35BE region. First, the directions of effects of deficiencies g and i are different (Table 2): the mean longevity of Df g/2b is greater than that of Df g/Ore, whereas the mean longevity of Df i/2b is less than that of Df i/Ore. This difference in the direction of effects is significant. We performed a two-way analysis of variance with deficiency genotype (G: g, i) and line (L: 2b, Ore) as fixed cross-classified effects. The L x G interaction term was significant, indicating a significant difference in the directions of effects of deficiencies (Table 2). There are two possible interpretations of these results. First, this region may contain two female-specific QTL. In this case, the most probable hypothesis is that one QTL is located at 35BC and the other QTL is located outside deficiency g but inside deficiency i, i.e., at 35CE. Second, it is possible that a difference in genetic background can account for the different directions of effects on longevity of deficiencies i and g. In this case, a single QTL affecting longevity is located at 35BC. Neither interpretation is consistent with the consideration of deficiency h as complementing the Oregon and 2b life span phenotypes, since this deficiency uncovers at least one of the putative QTL. Thus, we define the region containing the putative QTL as the largest interval defined by these analyses, 35BE. While we cannot exclude the possibility that two or more longevity QTL are located in this region, these data indicate that at least one female-specific QTL is at 35BE. The number of QTL in this region was further tested using additional deficiencies with informative breakpoints (see below).
|
The region 36E40B is covered by the overlapping deficiencies k, m, n, and p, and by deficiency q, which lies within p but does not overlap the others (Fig 1B). There were significant L effects on female longevity for deficiency k and significant L x G effects on female life span for deficiencies m and n (Table A2). The difference between the effects of the deficiencies in the Oregon and 2b backgrounds was significant while the difference between the effects of the balancer chromosome was not significant for deficiencies k and n; for deficiency m, the reverse was true. We thus consider deficiencies k and n to fail to complement the Oregon and 2b life span QTL in a manner consistent with an allelic interpretation, but not deficiency m. A QTL affecting female life span is implicated at 37C38A, the common region of overlap of deficiencies k and n. However, the mean longevity of Df k/Ore is greater than that of Df k/2b and the reverse relation is true for Df n, and this difference in the direction of effect is significant (Table 2). An alternative interpretation of these results is that there are two tightly linked QTL affecting female longevity in the region spanned by these deficiencies, one at 36E37C, at which the Oregon allele increases life span relative to the 2b allele, and one at 38A38B, at which the 2b allele increases life span relative to the Oregon allele. Further, the interpretation of a single QTL affecting female life span is not consistent with apparent quantitative complementation of deficiency m, but the hypothesis that there are two QTL with opposite allelic effects in Oregon and 2b is consistent with this result: deficiency m is not significant because it uncovers both putative QTL. The deficiency m breakpoints more precisely localize the first of these putative QTL to the 37BC region; the second remains at 38AB.
There were significant L and L x G effects on male life span for deficiency p and female life span for deficiency q and significant L effects on male life span for deficiency q (TABLE A2). In all cases there was a significant difference between the mean life span of Df/Ore and Df/2b, but not of Bal/Ore and Bal/2b genotypes. We therefore infer that there was a significant effect of deficiency p on male life span and of deficiency q on the life span of both sexes (Fig 1B). The differential sex-specific effects of these deficiencies seems inconsistent, since deficiency q lies within deficiency p. The apparent contradiction can be overlooked since analysis of variance showed that the difference in effects of deficiencies p and q on longevity of males and females was not significant (Table 2). The simplest interpretation of these results is that one QTL affecting longevity of both males and females is located at 38F39E, the region defined by the borders of deficiency q. The hypothesis of three QTL between 37B39E can be tested with further deficiencies in this region with informative breakpoints, as we have done for the 35BE region (see below).
Deficiency r does not overlap with any of the other deficiencies. A significant L effect on longevity was observed in crosses with this deficiency, both in males and females (Table A2, Fig 1B). Although the direction of the effect was the same in the two sexes, with Df r/Ore hemizygotes living longer than Df r/2b individuals (Table 2), the difference between Bal/Ore and Bal/2b genotypes was not significant in males but significant in females. Thus, according to our criteria for inferring failure to complement from allelic interaction, we interpret these results to indicate one male-specific QTL affecting longevity at 41A.
Deficiencies u and w exhibit significant L x G effects and deficiency v exhibits a significant L effect on male longevity (Table A2, Fig 1B). The difference between Df/Ore and Df/2b is significant and that between Bal/Ore and Bal/2b is not significant for deficiencies u and w, while the reverse is true for deficiency v. We therefore consider deficiencies u and w but not deficiency v in mapping QTL in this region. The difference between the effects of these deficiencies is not significant (Table 2). It is not clear whether deficiencies u and w overlap, due to the low precision of localization of the breakpoints of deficiency u (Table 1). If these deficiencies overlap, there is one QTL in the region of overlap at 44C (44C15). If these deficiencies do not overlap, there are two QTL affecting longevity in the 44BE region: one QTL is at 44BC and the other is at 44CE.
The quantitative deficiency mapping results are consistent with at least five to seven QTL on the second chromosome between 32F and 44E that affect variation in longevity between 2b and Oregon. Of these QTL, two or three are female specific, two or three are male specific, and one affects both sexes.
64C76B region:
Significant L and L x G effects on longevity were not found for deficiencies f, g, h, i, k, n, s, t, and u of the third chromosome (Table A2, Fig 2B). These deficiencies mark chromosomal fragments from 67A25 to 69B45, from 70C12 to 70D45, and from 71F14 to 74A3.
Deficiencies a, m, v, and x have significant L effects on female longevity (Table A2, Fig 2B) and do not overlap with any other deficiencies with significant effects nor with each other. The difference between Df/Ore and Df/2b genotypes was significant and the difference between Bal/Ore and Bal/2b genotypes was not significant for deficiencies a and v, whereas the reverse was true for deficiency x. Neither contrast was significant for deficiency m. We thus infer that there are two female-specific QTL affecting longevity, one at 64C65C and the other at 74AF (Table 3, Fig 2B).
|
Deficiency w has a significant L effect on male longevity (Table A2, Fig 2B), but neither the difference between Df/Ore and Df/2b genotypes nor Bal/Ore and Bal/2b genotypes was significant. No longevity QTL is inferred in the region uncovered by this deficiency.
Deficiencies e and d have significant L effects on male longevity and significant L x G effects on female longevity (Table A2, Fig 2B) and do not overlap with any other deficiencies with significant effects nor with each other. However, in all cases the differences between Df/Ore and Df/2b genotypes were not significant and those between Bal/Ore and Bal/2b genotypes were significant. No longevity QTL are inferred in the regions uncovered by these deficiencies.
Two overlapping deficiencies, b and c, have significant L effects on male longevity (Table A2, Fig 2B); in both cases the difference between Df/Ore and Df/2b genotypes is significant and the difference between Bal/Ore and Bal/2b genotypes is not significant. The direction of their effects is opposite, though, and this difference is highly significant (Table 3). In this case, there are two possible interpretations of the result. First, there may be two male-specific QTL located in the nonoverlapping regions of the two deficiencies: one at 65F66B8, the other at 66B1066C9. Alternatively, there may be one male-specific QTL in the region 66B810 that is common to both deficiencies b and c, and the opposite effects on longevity may be caused by epistatic effects that are not accounted for due to the uncontrolled genetic background of the deficiency chromosomes.
Three overlapping deficiencies, p, q, and r, have significant L and L x G effects on longevity, but the sex specificities of the effects are different (Table A2). Deficiency p has a significant L effect on male longevity and deficiency r has a significant L x G effect on female longevity. However, in both cases, the Bal/Ore - Bal/2b effect is significant while the Df/Ore - Df/2b contrast is not significant. Deficiency q has a significant L effect on male longevity and significant L and L x G effects on female longevity. The Df/Ore - Df/2b contrast is significant, and the Bal/Ore - Bal/2b contrast is not significant in both sexes. The most parsimonious interpretation of these results is that one QTL affecting both male and female longevity is located at 70E71C, the region for which deficiency q overlaps neither deficiency p nor deficiency r (Table 3).
The minimum number of QTL affecting variation in longevity between 2b and Oregon in the 64C76B cytological region varies from four to five, depending on the interpretation of the deficiency mapping results (Table 3). Of these QTL, two are female specific, one or two are male specific, and one affects both sexes.
Fine-scale mapping of the 35BE region:
We performed a more detailed analysis of the 35BE region to check the results of the quantitative deficiency mapping described above, to further evaluate the power of this method to resolve ambiguities observed in the initial mapping, and to map QTL with higher resolution. This region contains at least one putative female-specific QTL affecting longevity. Six additional deficiencies having one border within the region of interest were selected (Table 1, symbolized by Greek letters; Fig 3A) and crossed to Oregon and 2b. The longevity of the eight progeny genotypes was measured as described above, except that there were five replicate vials, not four, per genotype class. The experiment was nearly completely balanced (1197 flies in total). Mean longevities of the progeny resulting from these crosses are given in Table A1, and results of two-way analysis of variance of longevity are given in Table A2.
|
Including these data with those obtained in the initial screen, we have results of quantitative complementation tests from 13 deficiencies with one border within the 35BE region and one deficiency covering the whole chromosome fragment 35BE (deficiencies b, c, d, e, f, g, h, i,
,
,
,
,
; Table 1, Fig 3A). Failure to complement in a manner consistent with allelism was inferred for deficiencies g and i of the original 8 deficiencies tested in this region. Two of the 6 additional deficiencies tested, deficiencies
and
, do not have significant L and/or L x G effects on longevity (Table A2, Fig 3A). Deficiencies
and
have nominally significant L effects on female longevity, but in neither case is the difference between Df/Ore and Df/Bal genotypes significant. Deficiency
has a significant L effect on male longevity, and deficiency
has significant L x G effects on longevity in both sexes. The Df/Ore - Df/2b contrast is significant, and the Bal/Ore - Bal/2b contrast is not significant, for these deficiencies. Therefore, only 4 deficiencies in this region, g, i,
, and
, are considered to fail to complement Oregon and 2b alleles at loci affecting longevity, in a pattern that is consistent with an allelic interpretation.
We evaluated whether there was significant variation in the difference in mean life span between Oregon and 2b as hemizygotes with deficiencies g, i,
, and
by two-way analysis of variance of longevity for genotypes Df g/2b, Df g/Ore, Df i/2b, Df i/Ore, ... and Df
/2b, Df
/Ore. A significant L x G interaction term (where L is the main effect of line and G the main effect of deficiency genotype) indicates whether there are differences between the effects of deficiencies. This term was highly significant (P < 0.0001). Not only did the sex effect vary, but there were also differences in the direction of the effect among the deficiencies with effects on female life span: for deficiencies i and
, Df/Ore genotypes lived longer that Df/2b; for g the reverse was true (Table A1). These analyses suggest more than one QTL affecting life span in the 35BE region.
This inference is supported by the pattern of complementation and failure to complement. A QTL affecting either males or females at 35D5E1, at which the Oregon allele increases life span relative to the 2b allele, is consistent with all but one (deficiency g) of the quantitative deficiency complementation results for this region, with complementation by deficiency h defining the left border and failure to complement of deficiencies
and
defining the right border. In addition, a female-specific QTL at 35B9C3, at which the 2b allele increases life span relative to the Oregon allele, is implicated by considering the complementation effects of deficiencies b, c, d, e, g, and f. However, a two-QTL model fails to explain the complementation results for deficiencies
,
, h, and
. Postulating the existence of a third female-specific QTL at 35C3, with equivalent but opposite effects to those of the 35B9C3 QTL (i.e., the Oregon allele increases life span relative to the 2b allele), would account for the observation of complementation for deficiencies
,
, h,
, and
, which uncover both putative female-specific QTL (Fig 3A). Note that the location of the putative third QTL lies within the breakpoints of deficiencies g and
, pushing the limits of deficiency mapping using cytologically determined breakpoints to the maximum.
In summary, the quantitative deficiency complementation tests for the 35BE region are consistent with two closely linked female-specific longevity QTL at 35B9C3, with opposing allelic effects in Oregon and 2b, and a third QTL at 35D5E1. The effects of the 35D5E1 QTL in males and females appear to vary according to the genetic background. Longevity QTL with variable sex-specific effects depending on genetic background and external environment have been reported in previous studies of these lines (![]()
The 35BE region is part of the Adh gene region, arguably the best annotated genetic region of any higher eukaryote to date. The entire 2.9-Mb region includes 229 genes, of which 73 have been identified genetically, and 49 located on the sequence (![]()
![]()
The right breakpoint of deficiency
uncovers l(2)35Dh and that of deficiency
uncovers beat-B, placing the 35D5E1 QTL after the former gene, but including the latter (J. ROOTE, personal communication). Thus the left limit of this QTL is between BG:DS09217.4 or BG:DS09217.6 (it is not clear which of these predicted genes encodes l(2)35De and which corresponds to l(2)35Dh) and the right limit is BG:DS00365.4 (beat-B). This 185-kb region includes the genetically defined gene fs(2)35Ec, which has not been placed on the sequence, and 11 genes and predicted genes (![]()
The female-specific QTL in the 35B9C3 region is located between the left breakpoint of deficiency b, which uncovers vasa (vas), and that of deficiency g, which uncovers shuttlecraft (stc; J. ROOTE, personal communication). This small (<50 kb) region contains stc and three predicted genes (![]()
The female-specific QTL inferred at 35C3 now maps more precisely to the
200-kb interval between the left breakpoints of deficiencies g (stc) and
(which uncovers ms(2)35Ci; J. ROOTE, personal communication). This region also contains reduced (rd), l(2)35Cc, and gft, but only gft and ms(2)35Ci have been placed on the map. It also contains 13 additional genes and predicted genes, 2 of which must correspond to rd and l(2)35Cc (![]()
Segregation of 35BC longevity QTL in chromosomes extracted from natural populations:
We evaluated the life span of 10 inbred lines that were derived from a natural population (Table A3). There was considerable variation in longevity between the lines for both sexes. Mean longevity varied from 40 to 74 days in males and from 50 to 76 days in females. The effect of line (L) was highly significant in analyses of variance of longevity for the sexes separately and for sexes pooled (P < 0.0001 in all three ANOVAs; data not shown). In the two-way factorial analysis in which L and sex (S) are cross-classified main effects, the effect of S was significant (P < 0.02), but the L x S interaction term was not (P = 0.11; data not shown). Given that there is naturally occurring variation in life span among this set of lines, we can proceed to address the question of whether some fraction of this variation is attributable to segregation of alleles in the 35BC region, to which two putative QTL were mapped that affected the difference in longevity between the laboratory lines, 2b and Oregon.
Each of the 10 NC lines was crossed to deficiencies e, g, and h. Deficiency e does not uncover either QTL and was included as a control. Deficiency h uncovers the QTL at 35B9C3 and at 35C3, while deficiency g uncovers only the 35B9C3 QTL. The life span data were analyzed by three-way ANOVA for each deficiency, with L, S, and genotype (G, Df, or Bal) as cross-classified main effects. The L and S main effects are expected to be significant, on the basis of the results of analysis of the homozygous NC lines presented above. Significance of the G term would not be surprising, given the different background genotypes of the Df and Bal chromosomes, although an insignificant G term could be taken as evidence that the deficiency did not uncover naturally segregating longevity QTL. Significance of the L x G and L x G x S interaction terms, however, is interpreted as evidence for different QTL alleles in the region uncovered by the deficiencies that cause variation (or sex-specific variation, for the case of a significant L x G x S effect) in life span among the NC lines. The results of these analyses are straightforward. The L and S effects are highly significant (P < 0.001) for each of the three deficiencies. The effect of G is significant for deficiencies g (P < 0.003) and h (P < 0.0001) but not for deficiency e (P = 0.84). There is a significant L x G interaction for deficiency h (P = 0.04) and a significant L x G x S interaction for deficiency g (P = 0.01). Thus, these analyses are formally consistent with the segregation in nature of QTL that interact with deficiencies g and h, which might correspond to the two QTL segregating between Oregon and 2b.
We wished to determine which of the NC lines exhibited evidence of failure to complement these deficiencies and whether the data were consistent with one or two QTL in the 35B9C3 region. To evaluate the comparative effects of deficiencies, two-way analyses of variance of longevity were conducted for each NC line and sex within line, with cross (C: deficiencies e, g, or h) and genotype (G: Df or Bal) as fixed cross-classified main effects. In this analysis, a significant C x G interaction term is used as an indication of a difference between the effects of the deficiencies tested in the same line. However, as 10 unplanned comparisons are being made within each sex, the nominal significance level should be adjusted downward to 0.05/10 = 0.005.
The P values of the C x G interaction terms are given in Table 4, for the analyses including all three deficiencies in the model, and for the reduced model comparing the effects of deficiencies g and h. From the comparisons of the effects of all three deficiencies, it appears that there are significant differences between the three deficiencies for male life span in lines NC9, NC11, NC27, and NC33 and for female life span in lines NC9 and NC16. If the failure of Raleigh alleles to complement deficiencies g and h is attributable to the putative QTL uncovered by both (35B9C3), the expectation is that the C x G term will not be significant for the comparison of deficiencies g and h, in the lines where this term was significant in the analysis considering all three deficiencies. This was the case for female life span in lines NC9 and NC16 and for male life span in line NC33 (Table 4). However, if Raleigh alleles fail to complement deficiency h but not deficiency g, as would be expected if naturally occurring variation segregates at the 35C3 but not the 35B9C3 QTL, one would expect the C x G term to be significant for the comparison of deficiency g and deficiency h, in the lines where this term was significant in the analysis considering all three deficiencies. This was observed for male life span in lines NC9, NC11, and NC27 (Table 4).
|
While more complicated interpretations are possible, it seems clear that the observed pattern of failure of naturally occurring alleles to complement the three deficiencies is not consistent with a single QTL in the 35BC region and not inconsistent with segregation in nature at two QTL affecting longevity in this region. The effects of the putative naturally occurring alleles are sex specific, but not female specific. Possibly the sex specificity of these effects is dependent on genetic background (![]()
| DISCUSSION |
|---|
Identification of the genetic loci at which naturally occurring variation for quantitative traits segregates is a fundamental problem for human health, evolution, and applied breeding. Chromosomal regions to which QTL map can be identified by linkage to polymorphic molecular markers in particular mapping populations (![]()
![]()
![]()
According to the QTL mapping analyses of ![]()
24% of the Drosophila genome, illustrates two important points. (1) The intervals to which QTL are mapped by recombination represent the aggregate effects of all QTL in the interval and may be subdivided into multiple contributing QTL. (2) The genetic architecture of differences in life span between Oregon and 2b is consequently more complex than indicated by the initial genome scan for QTL segregating between the two strains.
The locations of the life span QTL inferred from deficiency mapping do not coincide exactly with the most likely map positions indicated by sequential multiple-marker analysis or with composite interval mapping. However, QTL locations inferred from composite interval mapping agree more closely overall with the deficiency mapping results than those inferred from sequential multiple-marker analysis. Both statistical analyses detected a QTL affecting female life span in the 33E34E region, but the deficiencies uncovering this region complemented the Oregon and 2b alleles. Rather, failure to complement was detected for deficiencies uncovering the 35BE region. A roo element insertion at 35B was segregating on the Oregon/2b recombinant inbred lines used to map the life span QTL, so it is puzzling why the more distal markers at 33E and 34E, and not the 35B marker, were associated with the life span QTL in both models detecting QTL by linkage to the markers. Both recombination mapping analyses detected a QTL affecting male life span in the pericentromeric region of the second chromosome, although the borders of the region inferred by composite interval mapping were wider than those inferred by sequential multiple-marker analysis. The former method encompassed three of the four remaining chromosome 2 QTL detected by deficiency mapping, while the latter method included two of these QTL. The two chromosome 3 QTL detected by sequential multiple marker analysis did not overlap any of the four QTL-containing regions delineated by deficiency mapping, whereas the regions containing life span QTL determined by composite interval mapping included two of the QTL detected by deficiency mapping.
The deficiency mapping analysis indicates that there are multiple closely linked QTL affecting variation in life span between Oregon and 2b in the chromosome 2 and chromosome 3 intervals studied. This is exactly the situation in which recombination-based QTL mapping methods can lead to biased estimates of QTL positions and effects (![]()
![]()
![]()
![]()
There is a good case for using the quantitative deficiency mapping approach as a screen for QTL affecting any quantitative trait of interest in Drosophila. Many artificial selection lines have been produced that differ in morphology, behavior, and physiology, as do isofemale lines derived from natural populations. Mapping QTL by linkage to molecular markers involves the further derivation of highly inbred lines with extreme values of the trait, finding informative molecular markers, generating a large number of individuals from a mapping population derived from the parental lines, and screening them for the phenotype of interest and their molecular marker genotypes. Linkage mapping is a long-term and laborious procedure, over which deficiency screens for QTL have several advantages:
- Selected or extreme lines can be utilized without further manipulation (although homozygosity of alternative QTL alleles in the strains tested obviously increases the power of the method). This could prove advantageous if the trait studied is subject to inbreeding depression.
- Development of molecular markers is not necessary, and thus deficiency mapping is technically easier than mapping QTL by linkage to polymorphic transposable element insertion sites, microsatellite markers, or other markers.
- The genotypes to be compared can be replicated to any desired level, giving similar advantages to the construction of RI lines with respect to increased power to detect QTL with small effects and testing for genotype-environment interactions.
- In favorable regions of the genome, well covered by deficiencies, deficiency mapping is capable of much finer resolution of QTL positions and discrimination of linked QTL than can be achieved using meiotic mapping with a similar size of experiment.
- Recombination is not uniform over the genome and is particularly restricted near the tips and bases of each chromosome. Small recombination distances in these regions thus correspond to large physical distances. Deficiency breakpoints are more uniformly distributed across each chromosome, giving better resolution in regions of restricted recombination.
- Deficiency mapping is easily extensible to multiple strains or lines, whereas recombination QTL mapping is usually restricted to one pair of lines at a time. Deficiency mapping thus potentially allows mapping of a larger sample of alleles of a particular QTL affecting a trait than linkage mapping and further enables inferences to be made about gene frequencies of segregating alleles in nature.
Accompanying these many advantages are disadvantages and caveats for the use of quantitative deficiency mapping to locate QTL:
- The major disadvantage of deficiency mapping is that a failure to complement, whether qualitative or quantitative, cannot be unambiguously attributed to an interaction between the Df and QTL alleles in the region uncovered by the Df (allelism), or to an interaction between the Df and QTL alleles elsewhere in the genome (epistasis). Widespread and large epistatic interactions between QTL can result in false positive results of quantitative deficiency tests, although one could argue that in this case the deficiency uncovers a gene in the same pathway as the QTL affecting the trait of interest. Imposition of constraints on the significance of differences between Df chromosomes and Bal chromosomes in the same genetic backgrounds, as has been done here, can serve to limit (but not eliminate) any confounding effects of epistasis on interpretation of statistical interactions in terms of allelic failure to complement. Further, 20 of the 47 deficiencies tested were not significantly associated with L or L x G effects on life span, suggesting that pervasive epistasis does not invalidate the approach.
- Estimates of the fraction of the Drosophila genome covered by deficiencies range from a minimum of 0.70 to a maximum of 0.80. QTL falling in the regions not covered by deficiencies cannot be detected using this method.
- Since deficiency mapping compares the mean phenotypes of hemizygotes and heterozygotes, the power of the method is greatest for recessive QTL alleles and is reduced for partially recessive/dominant and additive QTL. Dominant QTL cannot be detected using this method.
- Estimates of homozygous, heterozygous, and epistatic QTL effects can be obtained from experiments in which QTL are mapped by linkage to molecular markers, but not using quantitative deficiency mapping.
- The deficiency stocks vary greatly in genetic background, with regard to quantitative differences between different wild-type strains and qualitative differences in dominant and recessive mutant markers, both for the Df chromosomes and the balancer chromosomes over which they are maintained. The heterogeneous genetic backgrounds pose a problem for comparing effects across overlapping deficiencies. While variable effects could be due to multiple linked QTL, they could also be caused by differences in genetic background. This problem arose in the interpretation of numbers of life span QTL in regions in which overlapping deficiencies had different effects. We have shown that the effects of life span QTL are exquisitely sensitive to changes in genetic background as well as physical environment (
LEIPS and MACKAY 2000 ;
VIEIRA et al. 2000 ). In the future, it might be possible to discriminate between these alternative interpretations by substituting a common inbred background genotype into the parental lines to be tested and the deficiency stocks, thus ensuring all Df chromosomes are maintained against the same balancer chromosome.
Many candidate genes have been postulated to affect life span: genes involved in resistance to heat shock, physiological and oxidative stress, DNA repair and replication, cellular aging, metabolic energy storage, and loci with sex-specific effects on fertility and reproduction. Several key candidate loci, including the structural genes for Alcohol dehydrogenase, the small heat shock proteins, Superoxide dismutase, and Catalase, map to the regions also containing life span QTL and uncovered by deficiencies in this experiment. None of these loci remains a viable candidate locus that could harbor alleles affecting differences in life span between Oregon and 2b, on the basis of deficiency mapping results. This result does not mean that the other key candidate loci do not affect variation in life span in other strains, but does highlight the importance of testing for quantitative failure to complement between QTL and candidate locus alleles (![]()
![]()
We have detected a minimum of 11 life span QTL segregating between Oregon and 2b. Most of the genetic regions containing these QTL, as delineated by cytological deficiency breakpoints, include far too many loci to warrant formulating hypotheses as to which are likely candidates. However, it should be possible to combine higher resolution deficiency mapping with quantitative complementation tests to P-element insertions and mutations in these regions to refine the list of genetic loci that could correspond to life span QTL. Our fine-scale deficiency analysis of the 35BE region shows how powerful this approach can be.
The three putative longevity QTL in the 35BE region correspond to six genetically defined loci and 24 additional predicted genes. stc is a positional candidate for the 35B9C1 QTL. Stc protein shows sequence similarity to the mammalian transcription factor NF-X1 and also has a RNA-binding domain (![]()
![]()
-2 macroglobulins, and serine carboxypeptidases (![]()
![]()
![]()
![]()
| FOOTNOTES |
|---|
1 Present address: UMR 5558, Laboratoire de Biométrie, Génétique et Biologie des Populations, Université Claude Bernard Lyon 1, 43 bd. 11 novembre, 69622 Villeurbanne Cedex, France. ![]()
| ACKNOWLEDGMENTS |
|---|
We thank John Roote for his assistance in delineating deficiency breakpoints in the 35BE region and an anonymous reviewer for constructive comments on the original version of this manuscript. This work was supported by National Institutes of Health (NIH) grant GM45146 to T.F.C.M., Russian Fund of Basic Research grant 00-04-48770 to E.G.P., and NIH TW00997 to T.F.C.M. and E.G.P. This is a publication of the W. M. Keck Program for Behavioral Biology.
Manuscript received December 15, 1999; Accepted for publication July 7, 2000.
| APPENDIX 1 |
|---|


